Status
Conditions
Treatments
About
The purposes of this study are to 1) investigate potential speech, language, and psychosocial contributions to the experience of stuttering in monolingual and multilingual speakers, and to 2) evaluate interdisciplinary, telehealth, and speech-language pathology treatment methods and clinical training specific to fluency disorders.
Full description
Stuttering is a neurophysiological communication disorder characterized by a disruption in the forward flow of speech. Stuttering is multifactorial in nature, meaning there are several factors that likely to contribute to the development of stuttering in children and persistence of stuttering into adulthood. About 1% of the worldwide population stutters. In the United States, over 3 million people stutter. Research suggests people who stutter present with negative cognitive and affective components of the disorder, and that the general population holds negative perceptions of stuttering. Historically, people who stutter spend thousands of dollars on treatment that is not effective in mitigating the negative impact of stuttering on their overall communication and quality of life.
Speech-language pathologists evaluate and treat persons who stutter across the lifespan. Research suggests speech-language pathologists report fluency disorders (stuttering and cluttering) as the communication disorders with which they feel least competent and comfortable.
Thus, the purposes of this study are to 1) investigate potential speech, language, psychosocial, and motor contributions to stuttered speech production in monolingual and multilingual speakers and to 2) evaluate interdisciplinary, telehealth, and speech-language pathology treatment methods and clinical training tools specific to fluency disorders.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
A participant will be considered a child who stutters (ages 2-17 years) if
A participant will be considered an adult who stutters (18+ years) if
Exclusion criteria
• There are no exclusion criteria for persons who stutter.
Primary purpose
Allocation
Interventional model
Masking
3,000 participants in 1 patient group
Loading...
Central trial contact
Courtney T Byrd, PhD; Geoffrey A Coalson, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal